Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeed Regulatory News (SEED)

Share Price Information for Seed (SEED)

Share Price is delayed by 15 minutes
Get Live Data
3.00    0.00 (0.00%)
Bid:
2.80
Ask:
3.20
Spread: 0.40 (14.286%)
Market Cap: £5.64m
SEED Live PriceLast checked at - London Stock Exchange

Intraday Seed Share Chart

Director/PDMR Shareholding

2 Sep 2024 12:35

RNS Number : 5590C
Seed Innovations Limited
02 September 2024
 

2 September 2024

SEED Innovations Limited

("SEED" or the "Company")

 

Director Share Purchase

 

SEED Innovations Ltd, the AIM-quoted investment company offering exposure to disruptive, high-growth, life sciences and technology ventures typically inaccessible to everyday investors, is pleased to announce it has been informed today that on 2 September 2024, Ed McDermott, Chief Executive Officer at SEED, purchased a further 1,450,000 ordinary shares in the Company at an average price of 1.50p per share. Following this purchase Mr McDermott has a beneficial interest of 6,130,000 shares representing 3.18% of the issued share capital of the Company.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation No. 596/2014, which forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended).

- Ends -

 

For further information visit: www.seedinnovations.coor contact:

 

Ed McDermott 

Lance de Jersey 

SEED Innovations Ltd 

info@seedinnovations.co  

James Biddle 

Roland Cornish 

BeaumontCornishLimited

Nomad

(0)20 7628 3396 

Isabella Pierre 

Damon Heath 

Shard Capital Partners LLP 

Broker 

(0)20 7186 9927 

Ana Ribeiro

Isabel de Salis

Seb Weller

St Brides Partners Ltd

Financial PR 

seed@stbridespartners.co.uk 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Ed McDermott 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer at SEED Innovations Limited

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

SEED INNOVATIONS LIMITED

 

b)

 

LEI

 

 

213800KV6ETTB1BRZ435

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares

Identification code

GG00BRK9BQ81

b)

 

Nature of the transaction

 

 

On market purchase of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1.54p

150,000

1.474p

500,000

1.47p

250,000

1.523p

500,000

1.5475p

50,000

d)

 

Aggregated information

- Aggregated volume

1,450,000 Ordinary Shares

- Price

£21,743.75

e)

 

Date of the transaction

 

 

2 September 2024

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

SEED Innovations Limited

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

 

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights

 

Other (please specify) iii:

 

3. Details of person subject to the notification obligation iv

Name

Edward McDermott

City and country of registered office (if applicable)

London

4. Full name of shareholder(s) (if different from 3.) v

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached vi:

2 September 2024

6. Date on which issuer notified (DD/MM/YYYY):

02/09/ 2024

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

3.177%

 

 

6,130,000

Position of previous notification (if

applicable)

n/a

 

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GG00BRK9BQ81

6,130,000

0

3.177%

0

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

6,130,000

3.177%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

 

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Ed McDermott

3.177%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional information xvi

 

 

Place of completion

London

Date of completion

2 September 2024

 

 

Notes

Seed Innovations Ltd is an AIM quoted investment company offering exposure to disruptive, high-growth, life sciences and technology ventures typically inaccessible to everyday investors. Its strategy focuses on identifying early-stage opportunities with upcoming investment catalysts, alongside more mature investments providing near-term liquidity. With a portfolio of such investments and cash reserves, the company is agile and poised to capitalise swiftly on new investment opportunities.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBGDCSXGDGSD
Date   Source Headline
7th May 20267:00 amRNSInvestment in Feather Robotics, Inc.
1st May 20267:00 amRNS-RInvestee Company Update: Little Green Pharma
15th Apr 20267:00 amRNS-RInvestor Presentation
14th Apr 20267:00 amRNSInvestment in Clean Food Group Funding Round
23rd Feb 20262:47 pmRNS-RInvestor Presentation Update
11th Feb 20267:00 amRNS-RInvestor Presentation
14th Jan 20262:46 pmRNSInvestee Company Update: Little Green Pharma
9th Jan 20263:19 pmRNSDirector's Dealing
23rd Dec 20257:00 amRNSAppointment of Specialist Investment Consultant
23rd Dec 20257:00 amRNSAppointment of Specialist Investment Consultant
10th Dec 202510:49 amRNS-RInvestor Presentation Postponed
8th Dec 20252:30 pmRNS-RIntroduction to Newly Appointed Directors
4th Dec 20257:00 amRNSInterim Results
26th Nov 20257:00 amRNSBoard Appointments
13th Nov 202510:07 amRNS-RInvestee Company Update: Little Green Pharma Ltd
25th Sep 20257:00 amRNS-RInvestee Company Update: Clean Food Group
18th Sep 20257:00 amRNSHolding(s) in Company
11th Sep 20257:00 amRNSHolding(s) in Company
10th Sep 20259:11 amRNSHolding(s) in Company
8th Sep 202511:01 amRNSResult of Tender Offer
14th Aug 20257:00 amRNSDirectorship Changes
14th Aug 20257:00 amRNSTender Offer
13th Aug 20253:09 pmRNSResult of AGM
5th Aug 20251:39 pmRNSHolding(s) in Company
1st Aug 202510:55 amRNSHolding(s) in Company
18th Jul 20257:00 amRNSNotice of AGM & Publication of Circular
18th Jul 20257:00 amRNSInvestee Company Update: Little Green Pharma Ltd
17th Jul 20257:00 amRNSDivestment of Oxford BioDynamics Position
20th Jun 20257:00 amRNSFinal Results
30th May 20252:33 pmRNS-RInvestee Company Update: Little Green Pharma Ltd
28th May 20258:03 amRNSHolding(s) in Company
23rd May 20257:41 amRNSHolding(s) in Company
22nd May 20257:00 amRNSInvestee Company Update: Juvenescence Ltd
30th Apr 202512:13 pmRNSInvestee Company Update: Little Green Pharma Ltd
30th Apr 202510:48 amRNSHolding(s) in Company
17th Apr 20257:00 amRNSHolding(s) in Company
7th Apr 20251:35 pmRNSHolding(s) in Company
28th Mar 20257:00 amRNS-RNew Corporate Presentation
25th Feb 20253:08 pmRNSHolding(s) in Company
5th Feb 202510:44 amRNSInvestee Company Update: Little Green Pharma Ltd
31st Jan 20251:02 pmRNSHolding(s) in Company
31st Jan 202512:38 pmRNSInvestee Company Update: Little Green Pharma Ltd
16th Jan 20257:00 amRNS-R2025 New Year Statement
20th Dec 20242:19 pmRNS-RInvestee Company Update: Little Green Pharma Ltd
10th Dec 20247:07 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSHalf-year Report
11th Nov 202412:43 pmRNSPortfolio Update
17th Oct 202412:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
8th Oct 20247:24 amRNSPortfolio Update
24th Sep 20247:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.